OnCore Login

Return to Trial Database

HCRN-LYM21-544

Phase 2, open label, multicenter study of pacritinib in relapsed/refractory T-cell lymphoproliferative neoplasms

Status

Currently Enrolling

Cancer Type(s)

Lymphoma

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-LYM21-544 being conducted in.
City of Hope
The Ohio State University
University of Michigan Rogel Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278